JMIR Cancer

Wearable devices are becoming more ubiquitous and are capable of capturing health-relevant information that patients may be interested in sharing with their providers. However, limited research has been conducted on oncology provider perspectives on how these data could be used to inform cancer care.

Chronic myeloid leukemia (CML) has evolved into a chronic condition as a consequence of effective tyrosine kinase inhibitor (TKI) therapy, leading to an expanding demographic of patients necessitating lifelong monitoring. The use of eHealth solutions has the potential to facilitate sustainable and patient-centered care by enabling remote monitoring and enhancing guideline adherence. The Dutch CMyLife digital care platform incorporates a CML Dashboard intended for health care professionals (HCPs). This dashboard is designed to provide insight into real-world CML care and enable remote monitoring.

Quality of life (QoL) questionnaires are used in many disease areas to measure the burden that a disease causes for patients, which help provide insights into disease impact, identify unmet medical needs, and inform patient-centered drug development and value assessment for treatments. The collection of data imposes both a significant burden on patients as well as effort on health care personnel, thus incurring high costs for the health care system. Given that patients share detailed information about their condition and treatment experiences on social media and patient forums, an important research question is to what extent information about QoL can be obtained from patients’ online forum posts to potentially complement information obtained from questionnaires.

Breast cancer is a significant public health burden. Despite its critical role in preventing the recurrence of breast cancer, rates of long-term adherence to endocrine therapy (ET) remain low among certain breast cancer survivors. Using embedded sensors in smartphones and wearables, ecological momentary assessment data and health behavior theory may facilitate a richer understanding of the real-world context of medication-taking behaviors, which can aid in the development of personalized interventions.

Myeloid neoplasms (MNs) are most frequently diagnosed among adults aged 60 years and older. Cancer and chemotherapy can cause gait disturbances and increase fall risk in older adults with MNs. Exercise may improve gait, but there is a lack of research among older adults with MNs undergoing active chemotherapy.

With growing concern over high cervical and breast cancer mortality rates, this study was designed to examine the factors influencing attendance in breast and cervical cancer screening among working women in Japan by conducting a secondary analysis using nationally representative panel data from the Japanese Household Panel Survey (JHPS) and the Keio Household Panel Survey (KHPS) between 2019 and 2022, which showed that reduced screening attendance was associated with higher conscientiousness and neuroticism (possibly because of increased anxiety or fear of adverse results), suggesting that health-promoting behaviors and personality traits do not always align with preventive health actions, such as cancer screening.

Precision oncology (PO) improves and extends the lives of patients living with cancer, but multiple studies have documented its underuse in practice. Specifically, studies note a significant lack of PO use within the Veterans Affairs (VA) medical system. A paucity of implementation of PO in oncologic practice poses a significant barrier to providing the most up-to-date guideline-based care.

Fear of cancer recurrence (FCR) is prevalent among cancer survivors, affecting between 39% and 97% of patients. FCR is associated with impaired concentration, sleep disturbances, decreased quality of life, and increased psychological distress and health care use. To date, the literature lacks a review that summarizes the breadth of psychological interventions available for reducing fear of recurrence.

Oral medications are commonly used in the treatment of breast cancer (BC), despite high rates of nonadherence. As adherence is fundamental for optimal treatment, finding ways to effectively improve it is important. Artificial intelligence (AI) is being widely applied to health care.

Electronic medical record (EMR) systems have been associated with better clinical workflows and fewer documentation errors. However, evidence regarding their effect on time-sensitive leukemia care in public hospitals in Latin America remains limited.

Patients with head and neck cancer (HNC) face significant challenges in accessing coordinated care due to the complexity and multimodality of their treatment and the impact on vital functions. The COVID-19 pandemic has disrupted cancer care while accelerating the adoption of digital health solutions. Mobile health (mHealth) apps offer potential solutions for remote symptom monitoring, communication between patients and providers, and continuity of care. Nevertheless, their acceptance among patients with HNC remains limited due to age-related digital divides and concerns about accessibility.

There is a growing interest in characterizing the relationship between long-term physical activity (PA) habits and cancer-related outcomes such as treatment-related toxicities, recurrence, and complications. Wearable devices can provide critical information to achieve this goal; however, inferences are significantly influenced by device wear adherence.